Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
145.72
-1.72 (-1.17%)
At close: Sep 15, 2025, 4:00 PM EDT
146.21
+0.49 (0.34%)
After-hours: Sep 15, 2025, 4:08 PM EDT
Masimo Revenue
Masimo had revenue of $370.90M in the quarter ending June 28, 2025, with 7.85% growth. This brings the company's revenue in the last twelve months to $2.15B, up 25.86% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.
Revenue (ttm)
$2.15B
Revenue Growth
+25.86%
P/S Ratio
3.68
Revenue / Employee
$598,278
Employees
3,600
Market Cap
7.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
MASI News
- 4 days ago - Masimo Announces Expansion of Strategic Partnership with Philips - Business Wire
- 11 days ago - Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 18 days ago - Masimo to Present in the Wells Fargo Healthcare Conference - Business Wire
- 25 days ago - Masimo sues US Customs over approval of Apple Watch imports - Reuters
- 27 days ago - Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters - Business Wire
- 5 weeks ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 5 weeks ago - Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Masimo Reports Second Quarter 2025 Results - Business Wire